iBALT from COPD and IPF patients include IgA+ B cells, a feature that correlates with increased levels of circulating IgA autoantibodies directed against KRT18 and KRT19 (in COPD) or citrullinated proteins (in IPF). The gene discussed is KRT19; the disease is chronic obstructive pulmonary disease.